Published in J Clin Virol on February 01, 2004
Current advances in dengue diagnosis. Clin Diagn Lab Immunol (2004) 3.01
2nd International external quality control assessment for the molecular diagnosis of dengue infections. PLoS Negl Trop Dis (2010) 1.34
Enzyme-linked immunoassay for dengue virus IgM and IgG antibodies in serum and filter paper blood. BMC Infect Dis (2006) 1.18
First round of external quality assessment of dengue diagnostics in the WHO Western Pacific Region, 2013. Western Pac Surveill Response J (2015) 1.04
Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies. Viruses (2013) 0.91
First international diagnostic accuracy study for the serological detection of West Nile virus infection. BMC Infect Dis (2007) 0.91
External quality assessment of dengue and chikungunya diagnostics in the Asia Pacific region, 2015. Western Pac Surveill Response J (2016) 0.90
International external quality control assessment for the serological diagnosis of dengue infections. BMC Infect Dis (2015) 0.88
First international external quality assessment study on molecular and serological methods for yellow fever diagnosis. PLoS One (2012) 0.87
Second international diagnostic accuracy study for the serological detection of West Nile virus infection. PLoS Negl Trop Dis (2013) 0.82
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med (2006) 11.14
Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol (2002) 6.60
Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med (2006) 3.38
Studies of reservoir hosts for Marburg virus. Emerg Infect Dis (2007) 3.35
Three-dimensional radial ultrashort echo-time imaging with T2 adapted sampling. Magn Reson Med (2006) 2.43
RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene. Trans R Soc Trop Med Hyg (2007) 2.10
Outbreak of dengue and Chikungunya fevers, Toamasina, Madagascar, 2006. Emerg Infect Dis (2008) 2.02
For debate: is disinfection of specimens, which may contain unknown or bio-terrorist organisms, essential before electron microscopic examination? J Infect (2005) 1.98
Seroprevalence of dengue antibodies, annual incidence and risk factors among children in southern Vietnam. Trop Med Int Health (2005) 1.95
West Nile: worldwide current situation in animals and humans. Comp Immunol Microbiol Infect Dis (2004) 1.92
Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis (2003) 1.91
Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. J Clin Microbiol (2002) 1.86
Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res (2003) 1.82
S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol (2004) 1.80
Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol (2004) 1.74
Detection of immune-complex-dissociated nonstructural-1 antigen in patients with acute dengue virus infections. J Clin Microbiol (2003) 1.71
Different brain effects during chronic and acute sacral neuromodulation in urge incontinent patients with implanted neurostimulators. BJU Int (2006) 1.65
Crimean-Congo hemorrhagic fever in Kosovo. J Clin Microbiol (2002) 1.64
Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect (2002) 1.64
A clear and present danger: tick-borne diseases in Europe. Expert Rev Anti Infect Ther (2010) 1.61
Laboratory diagnosis of primary and secondary dengue infection. J Clin Virol (2004) 1.57
Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J Virol Methods (2003) 1.54
Coronavirus antibodies in African bat species. Emerg Infect Dis (2007) 1.54
Detection of yellow fever 17D genome in urine. J Clin Microbiol (2010) 1.52
Sequence analysis of L RNA of Lassa virus. Virology (2004) 1.50
Detection of West Nile virus lineages 1 and 2 by real-time PCR. J Virol Methods (2007) 1.49
Alkhumra, not Alkhurma, is the correct name of the new hemorrhagic fever flavivirus identified in Saudi Arabia. Intervirology (2012) 1.48
Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health (2002) 1.44
Multicentre evaluation of central nervous system infections due to Flavi and Phleboviruses in Turkey. J Infect (2012) 1.43
Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe. FEMS Yeast Res (2006) 1.43
The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization. Virology (2002) 1.41
[How to name in Spanish those viruses with a designation of its origin: Sin Nombre, Nápoles, West Nile]. Enferm Infecc Microbiol Clin (2009) 1.40
Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol (2004) 1.40
Dengue virus infection in travellers returning to Berlin, Germany: clinical, laboratory, and diagnostic aspects. Acta Trop (2004) 1.39
Vector competence of some French Culex and Aedes mosquitoes for West Nile virus. Vector Borne Zoonotic Dis (2008) 1.39
Larger than usual increase in cases of hantavirus infections in Belgium, France and Germany, June 2005. Euro Surveill (2005) 1.35
2nd International external quality control assessment for the molecular diagnosis of dengue infections. PLoS Negl Trop Dis (2010) 1.34
Development of guidelines for the surveillance of invasive mosquitoes in Europe. Parasit Vectors (2013) 1.33
Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J Clin Virol (2005) 1.33
First international quality assurance study on the rapid detection of viral agents of bioterrorism. J Clin Microbiol (2004) 1.33
Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J Virol (2004) 1.30
Lassa fever, Nigeria, 2003 and 2004. Emerg Infect Dis (2005) 1.28
Development of a panel of recombinase polymerase amplification assays for detection of biothreat agents. J Clin Microbiol (2013) 1.27
Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles. J Virol (2010) 1.27
Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods (2008) 1.26
West Nile virus, Guadeloupe. Emerg Infect Dis (2004) 1.24
West Nile virus outbreak in horses, southern France, 2000: results of a serosurvey. Emerg Infect Dis (2002) 1.23
Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. J Clin Microbiol (2012) 1.23
Towards an integrated approach in surveillance of vector-borne diseases in Europe. Parasit Vectors (2011) 1.21
Enzyme-linked immunoassay for dengue virus IgM and IgG antibodies in serum and filter paper blood. BMC Infect Dis (2006) 1.18
Potent inhibition of NTPase/helicase of the West Nile Virus by ring-expanded ("fat") nucleoside analogues. J Med Chem (2003) 1.15
Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. J Med Virol (2004) 1.14
Hantavirus disease outbreak in Germany: limitations of routine serological diagnostics and clustering of virus sequences of human and rodent origin. J Clin Microbiol (2007) 1.13
Severe acute respiratory syndrome: identification of the etiological agent. Trends Mol Med (2003) 1.13
Serologic evidence of West Nile virus infections in wild birds captured in Germany. Am J Trop Med Hyg (2007) 1.12
Rapid detection and differentiation of human pathogenic orthopox viruses by a fluorescence resonance energy transfer real-time PCR assay. Clin Chem (2004) 1.11
Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014. J Clin Virol (2015) 1.11
Acute disseminated encephalomyelitis following Plasmodium falciparum malaria caused by varicella zoster virus reactivation. Am J Trop Med Hyg (2005) 1.10
Detection of dengue nonstructural 1 (NS1) protein in Vietnamese patients with fever. Diagn Microbiol Infect Dis (2009) 1.10
External quality control assessment in PCR diagnostics of dengue virus infections. J Clin Virol (2004) 1.09
Factors affecting patterns of tick parasitism on forest rodents in tick-borne encephalitis risk areas, Germany. Parasitol Res (2010) 1.09
Alkhumra (Alkhurma) virus outbreak in Najran, Saudi Arabia: epidemiological, clinical, and laboratory characteristics. J Infect (2010) 1.08
Accumulation of pathological prion protein PrPSc in the skin of animals with experimental and natural scrapie. PLoS Pathog (2007) 1.08
SARS molecular detection external quality assurance. Emerg Infect Dis (2004) 1.08
False-negative results of PCR assay with plasma of patients with severe viral hemorrhagic fever. J Clin Microbiol (2002) 1.07
Serological differentiation of infections with dengue virus serotypes 1 to 4 by using recombinant antigens. J Clin Microbiol (2002) 1.07
Quantitative detection and biological propagation of scrapie seeding activity in vitro facilitate use of prions as model pathogens for disinfection. PLoS One (2011) 1.05
17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005. Vaccine (2006) 1.05
Chikungunya outbreak in a rural area of Western Cameroon in 2006: A retrospective serological and entomological survey. BMC Res Notes (2010) 1.05
Characterisation of human tick-borne encephalitis virus from Sweden. J Med Virol (2003) 1.05
Tick burden on European roe deer (Capreolus capreolus). Exp Appl Acarol (2010) 1.05
Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity. J Med Virol (2003) 1.04
SARS transmission and commercial aircraft. Emerg Infect Dis (2004) 1.04
Rift Valley fever virus infection among French troops in Chad. Emerg Infect Dis (2003) 1.03
Coordinated implementation of chikungunya virus reverse transcription-PCR. Emerg Infect Dis (2009) 1.03
Type 1 diabetes in Swedish bank voles (Clethrionomys glareolus): signs of disease in both colonized and wild cyclic populations at peak density. Ann N Y Acad Sci (2003) 1.00
Imported Crimean-Congo hemorrhagic Fever. J Clin Microbiol (2005) 0.99
Strain-specific antibody response to Lassa virus in the local population of west Africa. J Clin Virol (2007) 0.99
Characterization of imidazo[4,5-d]pyridazine nucleosides as modulators of unwinding reaction mediated by West Nile virus nucleoside triphosphatase/helicase: evidence for activity on the level of substrate and/or enzyme. Antimicrob Agents Chemother (2002) 0.98
Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015. Euro Surveill (2015) 0.97
West Nile virus monitoring of migratory and resident birds in Germany. Vector Borne Zoonotic Dis (2010) 0.97
Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. Clin Infect Dis (2009) 0.97
Fast, broad-range disinfection of bacteria, fungi, viruses and prions. J Gen Virol (2009) 0.97
First international external quality assessment of molecular detection of Crimean-Congo hemorrhagic fever virus. PLoS Negl Trop Dis (2012) 0.96
Dengue antibody prevalence in German travelers. Emerg Infect Dis (2005) 0.96
High yields of stable and highly pure nucleocapsid proteins of different hantaviruses can be generated in the yeast Saccharomyces cerevisiae. J Biotechnol (2004) 0.96
Genome analysis of Rift Valley fever virus, Mayotte. Emerg Infect Dis (2012) 0.96
Immune response during adverse events after 17D-derived yellow fever vaccination in Europe. J Infect Dis (2008) 0.96
Activation of the cytokine network and unfavorable outcome in patients with yellow fever. J Infect Dis (2004) 0.95
A new quantitative real-time reverse transcriptase PCR assay and melting curve analysis for detection and genotyping of Ljungan virus strains. J Virol Methods (2006) 0.95